List of insiders holdings for Werewolf Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
MPM BioVentures 2014 L.P. MPM BioVentures 2014 (B) L.P. MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd MPM Asset Management Investors BV2014 LLC 10% Owner | 2021-05-14 17:18:40 | 6,731,087 0 | 6,731,087 | Form 13D |
GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner | 2021-05-06 16:19:54 | 0 6,672,183 | 6,672,183 | Form 4 |
Asanuma Sakae Director 10% Owner | 2021-05-04 16:31:20 | 0 5,866,830 | 5,866,830 | Form 4 |
Taiho Ventures LLC 10% Owner | 2021-05-13 16:30:34 | 2,068,909 0 | 2,068,909 | Form 13D |
Arkin Bio Ventures 2 L.P. Arkin Bio Ventures GPGP Ltd. Arkin Moshe 10% Owner | 2021-05-10 11:21:05 | 2,046,634 0 | 2,046,634 | Form 13D |
Longwood Fund III GP LLC Longwood Fund III L.P. 10% Owner | 2021-05-14 16:42:01 | 1,677,082 0 | 1,677,082 | Form 13G |
UPMC 10% Owner | 2021-05-04 16:30:22 | 1,097,756 0 | 1,097,756 | Form 4 |
Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 2022-02-11 16:11:11 | 958,125 0 | 958,125 | Form 13G |
Sphera Global Healthcare Management LP Sphera Global Healthcare GP Ltd. SPHERA FUNDS MANAGEMENT LTD. 10% Owner | 2021-05-04 13:21:04 | 0 787,997 | 787,997 | Form 4 |
HBM Healthcare Investments (Cayman) Ltd. 10% Owner | 2021-05-05 16:00:36 | 625,995 0 | 625,995 | Form 4 |
HICKLIN DANIEL J See Remarks | 2024-01-04 16:26:36 | 435,000 0 | 435,000 | Form 4 |
Isaacs Randi Chief Medical Officer | 2024-01-04 16:33:19 | 200,000 0 | 200,000 | Form 4 |
Seidel-Dugan Cynthia Chief Scientific Officer | 2024-01-04 16:30:10 | 150,000 0 | 150,000 | Form 4 |
Trost Timothy W. Chief Financial Officer | 2024-01-04 16:40:19 | 150,000 0 | 150,000 | Form 4 |
Karunatilake Chulani Chief Technology Officer | 2024-01-04 16:30:47 | 150,000 0 | 150,000 | Form 4 |
Lubman Ellen Chief Business Officer | 2024-01-04 16:37:14 | 131,900 0 | 131,900 | Form 4 |
Leonard Reid Chief Operating Officer | 2023-01-09 21:34:46 | 93,600 0 | 93,600 | Form 4 |
Lazarus Alon Director | 2024-05-24 19:44:22 | 17,500 0 | 17,500 | Form 4 |
EVNIN LUKE Director | 2024-05-24 19:45:17 | 17,500 0 | 17,500 | Form 4 |
Sherman Michael A. Director | 2024-05-24 19:45:59 | 17,500 0 | 17,500 | Form 4 |
Chatterjee Meeta Director | 2024-05-24 19:46:59 | 17,500 0 | 17,500 | Form 4 |
Morrison Briggs Director | 2024-05-24 19:49:25 | 17,500 0 | 17,500 | Form 4 |
DiRocco Derek Director | 2024-05-24 19:52:50 | 17,500 0 | 17,500 | Form 4 |
RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2024-05-24 19:56:42 | 0 17,500 | 17,500 | Form 4 |
Atkins Michael B. Director | 2024-05-24 19:48:47 | 6,723 0 | 6,723 | Form 4 |